Cover Image

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY

Show other versions (1)

Characteristics and classification of different patterns of paroxysmal atrial fibrillation are presented. Main indications to restoration of sinus rhythm are discussed. The features of main medications used to terminate of atrial fibrillation are given. The choice of antiarrhythmic drug is considera...

Full description

Saved in:

Bibliographic Details
Main Author:	B. A. Tatarskii (Author)
Format:	Book
Published:	Столичная издательская компания, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015)

Pharmacological cardioversion of atrial fibrillation paroxysm in elderly and senile patients at prehospital stage
by: Andrei V. Syrov
Published: (2021)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019)

Efficiency and safety of pharmacological cardioversion for atrial fibrillation
by: Aleksei V. Tarasov
Published: (2021)

Electric cardioversion as therapeutic modality in patients with atrial fibrillation
by: Raúl Joaquín Varela García
Published: (2018)

Paroxysmal atrial fibrillation in cryptogenic stroke
by: Neha S Dangayach, et al.
Published: (2011)

Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation
by: N. A. Novikova, et al.
Published: (2016)

Physical rehabilitation in idiopathic paroxysmal atrial fibrillation
by: O. D. Lebedeva
Published: (2020)

Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment
by: O. R. Eshmatov, et al.
Published: (2023)

FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW
by: S. A. Zenin, et al.
Published: (2015)

FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW
by: S. A. Zenin, et al.
Published: (2015)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2019)

THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: S. N. Tereshchenko, et al.
Published: (2016)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015)

Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative?
by: I. A. Zaigraev, et al.
Published: (2023)

Changes in Arterial Wall Stiffness in Patients with Obesity and Paroxysmal Form of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2020)

Paroxysmal Atrial Fibrillation Induced by Ciprofloxacin: A Rare Adverse Effect
by: Fatma Hammami, et al.
Published: (2020)

Effect of cryoballoon ablation parameters on recurrence in patients with paroxysmal atrial fibrillation
by: Abdullah Orhan Demirtaş, et al.
Published: (2019)

Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2018)

FEATURES OF DAILY ECG MONITORING IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND ACCOMPANYING OBESITY
by: Yuriy Kovbasniuk
Published: (2015)

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE
by: L. E. Kuvshinova, et al.
Published: (2015)

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE
by: L. E. Kuvshinova, et al.
Published: (2015)

Successful ablation of paroxysmal atrial fibrillation originating in left atrial appendage with single shot cryoballoon technique
by: Uğur Canpolat, et al.
Published: (2017)

Predictors of class IC antiarrhythmic drugs efficacy in patients with paroxysmal form of atrial fibrillation
by: Manizha A. Khalikova, et al.
Published: (2023)

Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients
by: Kadri Murat Gürses, et al.
Published: (2019)

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE
by: I. V. Graifer, et al.
Published: (2016)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020)

Left Atrial Strain Helps Identifying the Cardioembolic Risk in Transient Ischemic Attacks Patients with Silent Paroxysmal Atrial Fibrillation
by: Arnăutu SF, et al.
Published: (2022)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023)

Association of plasma fibronectin level with left atrial electrical and structural remodelling in lone paroxysmal atrial fibrillation: a cross-sectional study
by: Uğur Canpolat, et al.
Published: (2015)

QDOT MICRO versus THERMOCOOL SMARTTOUCH and THERMOCOOL SMARTTOUCH Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation
by: Jose Osorio, et al.
Published: (2023)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015)

Successful treatment of neonatal atrial flutter by synchronized cardioversion: case report and literature review
by: Monika Wójtowicz-Marzec, et al.
Published: (2020)

Nutritional Insights: How Food Choices Affect Atrial Fibrillation
by: Daniel Gondko, et al.
Published: (2024)

Propafenone-induced liver injury in an elderly patient with paroxysmal atrial fibrillation--a new case report and literature review
by: Katarzyna Giedzicz, et al.
Published: (2023)

NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: Ju. P. Skirdenko, et al.
Published: (2018)

Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction
by: Ya. G. Bozhko, et al.
Published: (2020)